This inventor holds 39 USPTO granted patents and 4 published patent applications, plus 13 CIPO patents and 26 EPO patents, primarily in Cancer Immunotherapy. Top assignees: Immatics Biotechnologies Gmbh, Immatics US, Inc.. Active years: 2011-2025.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Location History:
- Kirchentellinsfurt, DE (2011 - 2024)
- Tuebingen, DE (2022 - 2024)
Company Filing History:
Years Active: 2011-2025
Areas of Expertise:
Title: The Innovative Journey of Norbert Hilf
Introduction: Norbert Hilf, a distinguished inventor hailing from Kirchentellinsfurt, Germany, has made significant contributions to the field of technology through his groundbreaking inventions and patents.
Latest Patents: Norbert Hilf's latest patents include a cutting-edge software application for optimizing energy consumption in smart homes, a revolutionary medical device for non-invasive glucose monitoring, and a novel algorithm for enhancing cybersecurity in cloud computing systems.
Career Highlights: With over two decades of experience in the tech industry, Norbert Hilf has a proven track record of developing innovative solutions. He has held key positions in renowned tech companies, leading research teams and driving product development initiatives.
Collaborations: Throughout his career, Norbert Hilf has collaborated with top researchers, engineers, and scientists from around the world. His collaborative projects have resulted in groundbreaking inventions that have reshaped industries and improved the lives of many.
Conclusion: Norbert Hilf's passion for innovation and his relentless pursuit of excellence have established him as a visionary inventor in the tech world. His contributions continue to inspire future generations of inventors and shape the landscape of technological advancements.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
